Close this search box.

The Institute for Clinical and Economic Review finds new treatments for atopic dermatitis to be cost effective – justifying health plan coverage for the medications. But methodological missteps invite questions about how secure patients’ access to the treatments will be.

View the Graphic

Leave a Reply

Your email address will not be published. Required fields are marked *